FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A. [electronic resource]
- Transplantation Apr 2003
- 945-52 p. digital
Publication Type: Journal Article
0041-1337
10.1097/01.TP.0000058469.38572.10 doi
Animals Chronic Disease Complement C3--metabolism Coronary Vessels--drug effects Cyclosporine--therapeutic use Drug Therapy, Combination Endothelium, Vascular--metabolism Fingolimod Hydrochloride Graft Rejection--drug therapy Heart Transplantation Immunoglobulin G--metabolism Immunohistochemistry Immunosuppressive Agents--therapeutic use Lymphocyte Subsets--drug effects Lymphocytes--drug effects Male Monocytes--pathology Myocardium--metabolism Propylene Glycols--therapeutic use Rats Sphingosine--analogs & derivatives